DMYTRENKO, I. V.; MINCHENKO, Z. M.; FEDORENKO, V. V.; DYAGIL, I. S. SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS. International Journal of Medicine and Medical Research, v. 5, n. 1, p. 33-39, 11 Jul. 2019.